FDA.reportPublic FDA data

coagulation factor VIIa (recombinant) 1 MCG Injection

RxCUI
798102
RxNorm name
coagulation factor VIIa (recombinant) 1 MCG Injection
Display name
coagulation factor VIIa (recombinant) 1 MCG Injection
Full name
coagulation factor VIIa (recombinant) 1 MCG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103665Novoseven, Novoseven RtCoagulation Factor VIIa (Recombinant)351(a)Disc2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ea65c32f-8518-4383-b621-17056c0eebc0coagulation factor VIIa (recombinant) 1 MCG Injection [PSN] · eptacog alfa activated 0.001 MG Injection [SCD] · coagulation factor VIIa recombinant 1 MCG Injection [SY] · eptacog alfa activated 1 MCG Injection [SY]421These highlights do not include all the information needed to use NOVOSEVEN RT safely and effectively. See full prescribing information for NOVOSEVEN RT. NOVOSEVEN RT (coagulation Factor VIIa, recombinant) lyophilized powder for solution, for intravenous use Initial U.S. Approval: 199920200710